Literature DB >> 32547687

Pentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion.

Marijan Kolovrat1, Slaven Gojkovic1, Ivan Krezic1, Dominik Malekinusic1, Borna Vrdoljak1, Katarina Kasnik Kovac1, Tamara Kralj1, Domagoj Drmic1, Ivan Barisic1, Katarina Horvat Pavlov1, Andreja Petrovic1, Antonija Duzel1, Mario Knezevic1, Ivan Mirkovic1, Antonio Kokot1, Alenka Boban Blagaic1, Sven Seiwerth1, Predrag Sikiric2.   

Abstract

BACKGROUND: The Pringle maneuver [portal triad obstruction(PTO)] provides huge disturbances during ischemia and even more thereafter in reperfusion. Contrarily, a possible solution may be stable gastric pentadecapeptide BPC 157, with already documented beneficial effects in ischemia/reperfusion conditions. Recently, BPC 157, as a cytoprotective agent, successfully resolved vessel occlusions in rats (ischemic colitis; deep vein thrombosis, superior anterior pancreaticoduodenal vein; bile duct cirrhosis) through rapid collateral vessel recruitment to circumvent vessel occlusion. Thereby, medication BPC 157 regimens were administered as a single challenge before and during ischemia or, alternatively, at various time points during reperfusion. AIM: To introduce BPC 157 therapy against pringle maneuver-damage.
METHODS: In deeply anesthetised rats, the portal triad was clamped up for 30 min. Rats then underwent reperfusion for either 15 min or 24 h. Medication [(10 µg, 10 ng/kg) regimens, administered as a single challenge] picked (a) ischemia, PTO period [at 5 min before (ip) or at 5 or 30 min of ligation time (as a bath to PTO)] or (b) reperfusion, post-PTO period [at 1 or 15 min (bath during surgery) or 24 h (ip) reperfusion-time]. We provided gross, microscopy, malondialdehyde, serum enzymes, electrocardiogram, portal, caval, and aortal pressure, thrombosis and venography assessments.
RESULTS: BPC 157 counteracts electrocardiogram disturbances (increased P wave amplitude, S1Q3T3 QRS pattern and tachycardia). Rapidly presented vascular pathway (portal vein-superior mesenteric vein-inferior mesenteric vein-rectal veins-left ileal vein-inferior caval vein) as the adequate shunting immediately affected disturbed haemodynamics. Portal hypertension and severe aortal hypotension during PTO, as well as portal and caval hypertension and mild aortal hypotension in reperfusion and refractory ascites formation were markedly attenuated (during PTO) or completely abrogated (reperfusion); thrombosis in portal vein tributaries and inferior caval vein or hepatic artery was counteracted during portal triad obstruction PTO. Also, counteraction included the whole vicious injurious circle [i.e., lung pathology (severe capillary congestion), liver (dilated central veins and terminal portal venules), intestine (substantial capillary congestion, submucosal oedema, loss of villous architecture), splenomegaly, right heart (picked P wave values)] regularly perpetuated in ischemia and progressed by reperfusion in Pringle rats.
CONCLUSION: BPC 157 resolves pringle maneuver-damage in rats, both for ischemia and reperfusion. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  BPC 157; Caval hypertension; Ischemia; Portal hypertension; Pringle maneuver; Rats

Year:  2020        PMID: 32547687      PMCID: PMC7280862          DOI: 10.4254/wjh.v12.i5.184

Source DB:  PubMed          Journal:  World J Hepatol


  58 in total

1.  Active spleno-femoral shunt avoids splanchnic congestion during portal triad occlusion: an experimental study.

Authors:  E A Ribeiro; R J Cruz; L F Poli de Figueiredo; O Rojas; M Rocha e Silva
Journal:  Transplant Proc       Date:  2005-06       Impact factor: 1.066

Review 2.  Stable gastric pentadecapeptide BPC 157-NO-system relation.

Authors:  Predrag Sikiric; Sven Seiwerth; Rudolf Rucman; Branko Turkovic; Dinko Stancic Rokotov; Luka Brcic; Marko Sever; Robert Klicek; Bozo Radic; Domagoj Drmic; Spomenko Ilic; Danijela Kolenc; Gorana Aralica; Mirjana Stupnisek; Jelena Suran; Ivan Barisic; Senka Dzidic; Hrvoje Vrcic; Bozidar Sebecic
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

3.  Ethanol gastric lesion aggravated by lung injury in rat. Therapy effect of antiulcer agents.

Authors:  D Stancic-Rokotov; P Sikiric; S Seiwerth; Z Slobodnjak; J Aralica; G Aralica; D Perovic; T Anic; I Zoricic; G Buljat; I Prkacin; M Gjurasin; R Rucman; M Petek; B Turkovic; Z Ivasovic; V Jagic; M Staresinic; A Boban-Blagaic
Journal:  J Physiol Paris       Date:  2001 Jan-Dec

4.  BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats.

Authors:  Dean Strinic; Zeljka Belosic Halle; Kresimir Luetic; Ana Nedic; Igor Petrovic; Mario Sucic; Gordana Zivanovic Posilovic; Dijana Balenovic; Sanja Strbe; Mario Udovicic; Domagoj Drmic; Mirjana Stupnisek; Martina Lovric Bencic; Sven Seiwerth; Predrag Sikiric
Journal:  Life Sci       Date:  2017-08-07       Impact factor: 5.037

5.  Class side effects: decreased pressure in the lower oesophageal and the pyloric sphincters after the administration of dopamine antagonists, neuroleptics, anti-emetics, L-NAME, pentadecapeptide BPC 157 and L-arginine.

Authors:  Zeljka Belosic Halle; Josipa Vlainic; Domagoj Drmic; Dean Strinic; Kresimir Luetic; Mario Sucic; Maria Medvidovic-Grubisic; Tatjana Pavelic Turudic; Igor Petrovic; Sven Seiwerth; Predrag Sikiric
Journal:  Inflammopharmacology       Date:  2017-05-17       Impact factor: 4.473

6.  Heparin-binding epidermal growth factor-like growth factor protects rat intestine after portal triad clamping.

Authors:  Xinxin Liao; Liyan Chen; Wenguang Fu; Jie Zhou
Journal:  Growth Factors       Date:  2013-03-27       Impact factor: 2.511

7.  The protective effects of dexmedetomidine on the liver and remote organs against hepatic ischemia reperfusion injury in rats.

Authors:  Adnan Tüfek; Orhan Tokgöz; Ibrahim Aliosmanoglu; Ulaş Alabalik; Osman Evliyaoglu; Taner Çiftçi; Abdülmenap Güzel; Zeynep Baysal Yıldırım
Journal:  Int J Surg       Date:  2012-12-20       Impact factor: 6.071

8.  Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration. A comparative study with dopamine agonists and somatostatin.

Authors:  P Sikiric; S Seiwerth; Z Grabarevic; R Rucman; M Petek; I Rotkvic; B Turkovic; V Jagic; B Mildner; M Duvnjak
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

9.  Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro.

Authors:  Tonglie Huang; Kuo Zhang; Lijuan Sun; Xiaochang Xue; Cun Zhang; Zhen Shu; Nan Mu; Jintao Gu; Wangqian Zhang; Yukun Wang; Yingqi Zhang; Wei Zhang
Journal:  Drug Des Devel Ther       Date:  2015-04-30       Impact factor: 4.162

10.  Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine.

Authors:  Mirjana Stupnisek; Antonio Kokot; Domagoj Drmic; Masa Hrelec Patrlj; Anita Zenko Sever; Danijela Kolenc; Bozo Radic; Jelena Suran; Davor Bojic; Aleksandar Vcev; Sven Seiwerth; Predrag Sikiric
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

View more
  12 in total

1.  Therapy Effect of the Stable Gastric Pentadecapeptide BPC 157 on Acute Pancreatitis as Vascular Failure-Induced Severe Peripheral and Central Syndrome in Rats.

Authors:  Ivan Maria Smoday; Igor Petrovic; Luka Kalogjera; Hrvoje Vranes; Helena Zizek; Ivan Krezic; Slaven Gojkovic; Ivan Skorak; Klaudija Hriberski; Ivan Brizic; Milovan Kubat; Sanja Strbe; Ivan Barisic; Marija Sola; Eva Lovric; Marin Lozic; Alenka Boban Blagaic; Anita Skrtic; Sven Seiwerth; Predrag Sikiric
Journal:  Biomedicines       Date:  2022-06-01

2.  Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy.

Authors:  Darko Perovic; Marija Milavic; Stjepan Dokuzovic; Ivan Krezic; Slaven Gojkovic; Hrvoje Vranes; Igor Bebek; Vide Bilic; Nenad Somun; Ivan Brizic; Ivan Skorak; Klaudija Hriberski; Suncana Sikiric; Eva Lovric; Sanja Strbe; Milovan Kubat; Alenka Boban Blagaic; Anita Skrtic; Sven Seiwerth; Predrag Sikiric
Journal:  Curr Issues Mol Biol       Date:  2022-04-27       Impact factor: 2.976

3.  Bowel adhesion and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats.

Authors:  Lidija Berkopic Cesar; Slaven Gojkovic; Ivan Krezic; Dominik Malekinusic; Helena Zizek; Lovorka Batelja Vuletic; Andreja Petrovic; Katarina Horvat Pavlov; Domagoj Drmic; Antonio Kokot; Josipa Vlainic; Sven Seiwerth; Predrag Sikiric
Journal:  World J Gastrointest Pharmacol Ther       Date:  2020-11-08

4.  Clopidogrel-Induced Gastric Injury in Rats is Attenuated by Stable Gastric Pentadecapeptide BPC 157.

Authors:  Hailu Wu; Ming Wei; Nan Li; Qin Lu; Sachin Mulmi Shrestha; Jiacheng Tan; Zhenyu Zhang; Guoqiu Wu; Ruihua Shi
Journal:  Drug Des Devel Ther       Date:  2020-12-21       Impact factor: 4.162

5.  Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome.

Authors:  Predrag Sikiric; Anita Skrtic; Slaven Gojkovic; Ivan Krezic; Helena Zizek; Eva Lovric; Suncana Sikiric; Mario Knezevic; Sanja Strbe; Marija Milavic; Antonio Kokot; Alenka Boban Blagaic; Sven Seiwerth
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

Review 6.  Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.

Authors:  Sven Seiwerth; Marija Milavic; Jaksa Vukojevic; Slaven Gojkovic; Ivan Krezic; Lovorka Batelja Vuletic; Katarina Horvat Pavlov; Andrea Petrovic; Suncana Sikiric; Hrvoje Vranes; Andreja Prtoric; Helena Zizek; Tajana Durasin; Ivan Dobric; Mario Staresinic; Sanja Strbe; Mario Knezevic; Marija Sola; Antonio Kokot; Marko Sever; Eva Lovric; Anita Skrtic; Alenka Boban Blagaic; Predrag Sikiric
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

7.  BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats.

Authors:  Mirna Zlatar; Antonio Kokot; Lovorka Batelja Vuletic; Sanja Masnec; Tamara Kralj; Marija Milkovic Perisa; Ivan Barisic; Bozo Radic; Kristina Milanovic; Domagoj Drmic; Sven Seiwerth; Predrag Sikiric
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

8.  Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension.

Authors:  Mario Knezevic; Slaven Gojkovic; Ivan Krezic; Helena Zizek; Dominik Malekinusic; Borna Vrdoljak; Hrvoje Vranes; Tamara Knezevic; Ivan Barisic; Katarina Horvat Pavlov; Domagoj Drmic; Miro Staroveski; Antonija Djuzel; Zoran Rajkovic; Toni Kolak; Ivica Kocman; Eva Lovric; Marija Milavic; Suncana Sikiric; Ante Tvrdeic; Leonardo Patrlj; Sanja Strbe; Antonio Kokot; Alenka Boban Blagaic; Anita Skrtic; Sven Seiwerth; Predrag Sikiric
Journal:  Biomedicines       Date:  2021-05-26

9.  BPC 157 Therapy and the Permanent Occlusion of the Superior Sagittal Sinus in Rat: Vascular Recruitment.

Authors:  Slaven Gojkovic; Ivan Krezic; Hrvoje Vranes; Helena Zizek; Domagoj Drmic; Katarina Horvat Pavlov; Andrea Petrovic; Lovorka Batelja Vuletic; Marija Milavic; Suncana Sikiric; Irma Stilinovic; Mariam Samara; Mario Knezevic; Ivan Barisic; Ivica Sjekavica; Eva Lovric; Anita Skrtic; Sven Seiwerth; Predrag Sikiric
Journal:  Biomedicines       Date:  2021-06-28

10.  Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma.

Authors:  Tamara Kralj; Antonio Kokot; Mirna Zlatar; Sanja Masnec; Katarina Kasnik Kovac; Marija Milkovic Perisa; Lovorka Batelja Vuletic; Ana Giljanovic; Sanja Strbe; Suncana Sikiric; Slaven Balog; Bojan Sontacchi; Dijana Sontacchi; Matko Buljan; Eva Lovric; Alenka Boban Blagaic; Anita Skrtic; Sven Seiwerth; Predrag Sikiric
Journal:  Biomedicines       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.